Decision Resources, one of the
world’s leading research and advisory firms focusing on pharmaceutical and
healthcare issues, Read the rest of this entry »
Archive for December 3, 2008
Decision Resources, one of the
world’s leading research and advisory firms focusing on pharmaceutical and
healthcare issues, Read the rest of this entry »
Avamys A New Nasal Spray For Allergic Rhinitis To Ease Both Nose And Eye Symptoms In An Award Winning Device
03 Dec 2008
Avamys (fluticasone furoate), a new intranasal steroid (INS) manufactured by GlaxoSmithKline (GSK), launches in the UK today. In clinical trials, Avamys has shown significant improvements in both nasal and ocular symptoms in adult and adolescent patients with seasonal allergic rhinitis (SAR).1 Avamys has also demonstrated improvement in health-related quality of life domains, including eye and sleep related improvements.2
Over a quarter of the UK population Read the rest of this entry »